GlassFlow Secures $4.8M to Enable Python Devs to Build Event-Driven Data Pipelines in Minutes, Backed by Upfront Ventures

October 29, 2024

October 29th, 2024 – GlassFlow, a Berlin-based startup enabling data teams to build event-driven data pipelines in Python within minutes, has raised $4.8 million in seed funding. The round was led by Upfront Ventures, with participation from High-Tech Gründerfonds, Robin Capital, TinyVC, the CEO of Weaviate and leading operators at Fivetran, dbt Labs and Redis.


Event-driven data pipelines are critical for AI applications like real-time recommendations, predictive maintenance, and dynamic pricing, but building and maintaining them is complex. It typically takes midsize companies 6 to 9 months to implement such solutions, with data engineers spending 50% of their time on maintenance. The complexity is driven by tools that are built for Java and Scala, leaving Python developers to create their own inefficient, hard-to-maintain solutions. GlassFlow simplifies this process for Python developers, reducing setup time, lowering maintenance costs, and speeding up project delivery.

Introducing GlassFlow

Python has a market share of more than 25% and is the most popular programming language worldwide. It has become the go-to language for data processing due to its simplicity and strong community. GlassFlow is built for Python devs and providing a fully managed streaming platform, enabling developers to create data pipelines without infrastructure hassles. With serverless execution, built-in connectors, and automatic setup, teams can build end-to-end pipelines in just 15 minutes. Founders Armend Avdijaj and Ashish Bagri bring over a decade of experience building data products and designed GlassFlow to meet the needs of Python developers.

“Our mission is to provide the simplest, most powerful platform for Python developers to build data streaming pipelines,” said Armend Avdijaj, Co-Founder and CEO of GlassFlow. “By making data streaming accessible for small to mid-size data teams and organizations, GlassFlow can save users hundreds of thousands of dollars in the process. We aim to switch data engineers’ focus from building the infra to spending time creating value for the businesses.”

“What drew me to Armend and Ashish is their focus on addressing a key gap in the market for a more user-friendly, flexible streaming solution,” said Kevin Zhang, Partner at Upfront Ventures. “As Python continues to dominate the modern data ecosystem, GlassFlow is well-positioned to empower the next generation of developers, giving them the tools they need to unlock the full potential of event-driven pipelines.”

With its new funding, GlassFlow is now available and has plans to continue expanding its platform’s capabilities, including enabling data transformations like stateful functions, chaining, data lineage and giving users the flexibility to host GlassFlow on their own cloud infrastructure. To date, more than 60 companies have used GlassFlow, including data engineers from Babbel, Deloitte and Juro.

To learn more and sign up, visit www.glassflow.dev.

Team of GlassFlow (Image: GlassFlow)

About GlassFlow
GlassFlow is a Berlin-based startup enabling Python developers to build event-driven data pipelines within minutes. The platform features built-in connectors, managed infrastructure, and a serverless transformation engine to execute Python functions. By simplifying the creation of end-to-end pipelines, GlassFlow supports AI applications, real-time processing infra, and IoT use cases. Organizations using GlassFlow benefit from reduced setup time, lower maintenance costs, and faster project delivery, allowing teams to focus on innovation rather than infrastructure management.

Contact
Armend Avdijaj
armend@glassflow.dev
www.glassflow.dev

About HTGF – High-Tech Gründerfonds 
HTGF is one of the leading and most active early-stage investors in Germany and Europe, financing start-ups in the fields of Deep Tech, Industrial Tech, Climate Tech, Digital Tech, Life Sciences and Chemistry. With its experienced investment team, HTGF supports start-ups in all phases of their development into international market leaders. HTGF invests in pre-seed and seed phases and can participate significantly in later-stage financing rounds. Across its funds, HTGF has over 2 billion euros under management. Since its inception in 2005, HTGF has financed more than 750 start-ups and achieved over 180 successful exits.  
Fund investors in the public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital as well as 45 companies and family offices.  
For more information, please visit HTGF.de or follow us on LinkedIn.   

Media contact
High-Tech Gründerfonds Management GmbH 
Tobias Jacob, Senior Marketing & Communications Manager  
T.: +49 228 – 82300 – 121 
t.jacob@htgf.de   

Stay up to date

Subscribe now and receive the latest press releases on investments and other news from High-Tech Gründerfonds. We inform you about important developments at HTGF and provide you with interesting news from our portfolio. Whether it’s a successful exit, a new exciting investment or HR news – you’ll be the first to know!

Press
6. February 2025

Modular. Data-driven. Connected. Avelios Medical secures €30 million from Sequoia Capital for its next-generation hospital information system

The funding round is one of the largest Series A rounds in digital health in recent months. Avelios Medical offers the HIS of the future: designed around hospital workflows, powered by modular microservices, and based on structured data to enable AI-driven care. Leading hospitals are successfully using Avelios Medical’s software as the modern alternative in the HIS market. Munich, February 6, 2025 – Avelios Medical, provider of a modern hospital information system (HIS), h
 
Press
4. February 2025

Akribion Therapeutics exits from stealth with €8m seed financing to pioneer RNA-guided, programmable cell depletion

Financing led by CARMA FUND and RV Invest with participation of High-Tech Gründerfonds and others Akribion is pioneering a unique, RNA-guided, nuclease-based technology for programmable cell depletion Experienced team with a background in biotechnology and company building led by co-CEO’s Dr. Michael Krohn and Lukas Linnig Dr. Paul Scholz, the principal inventor of G-dase E technology, joins as Head of Research and Development Akribion Therapeutics (“Akribion”), the earl